EUVIMEDEUVIMED entdecken
Crossref

Sugammadex for reversal of moderate-to-deep rocuronium block in a clinical setting: A retrospective report of 10 dogs

Manuel Martin-Flores

Veterinary Anaesthesia and Analgesia · 2024

DOI: 10.1016/j.vaa.2023.11.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Anaesthesia and Analgesia, 2024. Verfasst von Manuel Martin-Flores. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA. Electronic address: mm459@cornell.edu. Hauptthemen laut MEDLINE: gamma-Cyclodextrins, Neuromuscular Nondepolarizing Agents, Neuromuscular Blockade. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To compare recovery times of sugammadex with spontaneous recovery from rocuronium-induced neuromuscular block (NMB) in dogs. STUDY DESIGN: Retrospective, unmatchedcase-control study. ANIMALS: A total of 10 dogs administered sugammadex and 10 dogs recovering spontaneously from rocuronium-induced NMB. METHODS: Files of dogs administered rocuronium between March and August 2023 were inspected. The train-of-four (TOF) count at the time of sugammadex administration and the time between administration and TOF ratio >90% (recovery time) were recorded. The recovery time for those not administered reversal agents was considered from the first TOF value >0 until TOF ratio >90%. The dose of sugammadex and the cumulative dose of rocuronium were recorded. Rocuronium doses and recovery times were compared using Mann-Whitney tests. The coefficient of determination (R2) between the cumulative rocuronium dose and sugammadex dose and the recovery time were calculated. RESULTS: Dogs in the sugammadex and spontaneous recovery groups were administered intravenously (IV) 0.76 (0.4-2.6) and 0.61 (0.3-2.9) mg kg-1 of rocuronium, respectively (p = 0.325). Recovery time after 3.9 (2.9-5.5) mg kg-1 of sugammadex IV was 1 (1-3) minutes and was 20 (10-35) min for spontaneous recovery (p < 0.0001). The R2 for rocuronium and sugammadex doses and recovery times were 0.19 (p = 0.2) and 0.012 (p = 0.758). CONCLUSIONS AND CLINICAL RELEVANCE: Sugammadex 2.9-5.5 mg kg-1 reversed moderate (TOF count 1-3) or deep (TOF count 0) rocuronium-induced NMB within 3 minutes, substantially faster than spontaneous recovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

gamma-CyclodextrinsNeuromuscular Nondepolarizing AgentsNeuromuscular BlockadeDogsAnimalsSugammadexRocuroniumRetrospective StudiesAndrostanolsTime Factors

Stichwörter der Autor:innen

acceleromyographyneuromuscular blockreversaltrain-of-four

Substanzen

SugammadexRocuroniumgamma-CyclodextrinsNeuromuscular Nondepolarizing AgentsAndrostanols

Autor:innen und Institutionen

  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA. Electronic address: mm459@cornell.edu.

Zitieren

APA

Martin-Flores, M. (2024). Sugammadex for reversal of moderate-to-deep rocuronium block in a clinical setting: A retrospective report of 10 dogs. Veterinary Anaesthesia and Analgesia. https://doi.org/10.1016/j.vaa.2023.11.008

Vancouver

Martin-Flores M. Sugammadex for reversal of moderate-to-deep rocuronium block in a clinical setting: A retrospective report of 10 dogs. Veterinary Anaesthesia and Analgesia. 2024. doi:10.1016/j.vaa.2023.11.008

BibTeX
@article{MartinFlores2024,
  author = {Martin-Flores, Manuel},
  title = {Sugammadex for reversal of moderate-to-deep rocuronium block in a clinical setting: A retrospective report of 10 dogs},
  journal = {Veterinary Anaesthesia and Analgesia},
  year = {2024},
  doi = {10.1016/j.vaa.2023.11.008}
}
Kostenlos starten →